Home Hefei Second People's Hospital Successfully Completes Nation’s First Clinical Cases Using Xuanyu Medical’s RhythPulse® Pulsed Field Ablation System for Atrial Fibrillation

Hefei Second People's Hospital Successfully Completes Nation’s First Clinical Cases Using Xuanyu Medical’s RhythPulse® Pulsed Field Ablation System for Atrial Fibrillation

Oct 15, 2025 20:17 CST Updated 20:17
ShineyoMedical

Provider of Atrial Fibrillation Electrophysiology and Peripheral Vascular Intervention Solutions

Click the blue words to follow us

ENTERPRISE

Recently, under the leadership of Director Zhang Jing, the Department of Cardiology at Hefei Second People's Hospital, with the collaboration of Directors Xu Mingsheng and Zhang Ting, as well as the anesthesia department and medical staff, successfully applied ShineyoMedical's RhythPulse under the guidance of Director Xu Kai from Shanghai Chest Hospital.®Pulsed Field Ablation Catheter Performs Pulsed Field Ablation (PFA) for Two Patients with Atrial Fibrillation. This procedure is one of the first batch in China to use ShineyoMedical's RhythPulse.®The clinical application of pulsed ablation marks a new breakthrough in the cardiology department of our hospital, which has mastered another safe, efficient, and precise interventional technology in the field of arrhythmia treatment. This achievement represents a significant advancement in the interventional diagnosis and treatment of cardiovascular diseases as well as comprehensive atrial fibrillation management capabilities.

图片

Group Photo After Surgery

Patient Basic Information


Patient 1 is a 70-year-old male who has experienced recurrent chest tightness and palpitations for 3 years, with symptoms worsening over the past half day upon admission. Admission diagnosis: 1. Chronic heart failure 2. Coronary atherosclerotic heart disease 3. NYHA Class II cardiac function 4. Paroxysmal atrial fibrillation 5. Sjögren's syndrome 6. Ventricular standstill. The cardiology team led by Director Zhang Jing communicated with the family and decided to use ShineyoMedical RhythPulse.®-PFA Pulse Electric Field Ablation for patient treatment.

图片

Patient 2 is a 77-year-old female with recurrent dizziness for over 10 years, reoccurred with amaurosis for one week before admission. Admission diagnoses: 1. Atrial fibrillation 2. Acute exacerbation of chronic heart failure 3. Cardiac function Class II-III 4. Grade 3 hypertension (very high risk) 5. Multiple cerebral infarctions 6. Deep vein thrombosis of the lower extremities 7. Varicose veins of the lower extremities 8. Pulmonary shadow (nodule). Director Zhang Jing from the Cardiology Department and her team communicated with the family and decided to use ShineyoMedical RhythPulse.®-PFA Pulse Electric Field Ablation for patient treatment.


Surgical Procedure


Both patients underwent surgery under general anesthesia. After routine vascular puncture, the atrial septal puncture sheath was advanced via the inferior vena cava to the right atrium, and the atrial septum (anterior and inferior) was punctured to successfully establish access to the left atrium. The RhythPulse system from ShineyoMedical was used.®The 15mm catheter performed left atrial modeling and substrate mapping under the support of a three-dimensional system.

图片

After the modeling is completed, RhythPulse®The PFA catheter was delivered to the left upper pulmonary vein, where ablation was performed at the ostium and vestibule areas, successfully eliminating the pulmonary vein potential and achieving isolation. Subsequently, ablation was carried out sequentially on the left lower, right upper, and right lower pulmonary veins, successfully completing bilateral pulmonary vein electrical isolation. The entire ablation process took approximately 30 minutes.

图片

In this surgery, the cardiology team of Hefei Second People's Hospital successfully performed pulse ablation on the patient with rich experience and superb technology. The operation went smoothly, and the patient recovered well post-operation, with stable vital signs. This successful case not only demonstrates the hospital’s technical strength in the field of arrhythmia treatment but also brings hope of a cure to more patients with atrial fibrillation.

图片
图片

Intraoperative Highlights


Surgical Highlights


1、Shorten Operation Time:The average operation time is only 60 minutes, nearly one hour shorter than traditional radiofrequency ablation surgery;

2、Multiple Models, Multiple Choices:Ablation catheters with different diameters offer more options during the procedure;

3、3D Precision Positioning:Achieve precise targeted ablation through 3D, improving success rates.


Hospital Introduction


Hefei Second People's Hospital, established in 1950, was formerly the 521 Field Hospital of the Chinese People's Volunteer Army. After more than seventy years of development, it has become the largest comprehensive tertiary-level A hospital in eastern Hefei, integrating medical treatment, scientific research, teaching, prevention, health care, rehabilitation, emergency rescue, and elderly care. It is also the Hefei Hospital Affiliated to Anhui Medical University. In recent years, the hospital has been granted six National Natural Science Foundation projects, 215 provincial and municipal scientific research projects, won 39 provincial and municipal science and technology progress awards, and obtained 580 national patents. It has published over 4,000 papers in SCI, Chinese series, and core journals, and edited or co-edited 109 books. Upholding the spirit of "Unity, Dedication, Innovation, and Devotion," the hospital adheres to the development strategy of "Building the hospital with talent, promoting it through science and education, strengthening it with technology, and flourishing it with culture." It strives to become a modern research-oriented hospital with excellent technical expertise, high-quality services, a warm environment, a strong brand image, and high public satisfaction.

图片


Expert Profile


图片

Zhang Jing

Hefei Second People's Hospital

Chief Physician, Doctor of Medicine, Director of the Cardiology Department at Guangde Road Campus of Hefei Second People's Hospital. Master's degree supervisor at Anhui Medical University, Bengbu Medical College, and Wannan Medical College. Academic and technical leader in Hefei City and a reserve candidate. Specializes in the diagnosis and treatment of critical cardiac emergencies and arrhythmias. Has undergone advanced studies at Shandong Provincial Hospital and KH--Landshut Hospital in Munich, Germany. Serves as a committee member of the Cardiac Branch of the Chinese Society of Behavioral Medicine, standing committee member and deputy group leader of the Heart Failure Group under the Anhui Provincial Medical Association’s Critical Care Committee; Chairman of Hefei Medical Association’s Cardiac Critical Care Branch; Standing committee member of Hefei Cardiovascular Disease Quality Control Center, Hefei Chest Pain Center Alliance, Hefei Medical Association’s Pacing and Electrophysiology Branch, and Hefei Medical Association’s Cardiovascular Branch. In the past three years, has led three provincial and municipal research projects, published several high-quality papers as the first author and corresponding author, and received one third prize for scientific and technological progress in Hefei City and one third prize for scientific and technological progress in Anhui Province.

图片

Xu Kai

Shanghai Chest Hospital

Doctor of Medicine, Attending Physician in Cardiology, Youth Committee Member of the Shanghai Heart Rhythm Society, Member of the Pacing and Electrophysiology Branch of the Shanghai Biomedical Engineering Society. Specializes in the diagnosis and treatment of various types of tachyarrhythmias such as atrial fibrillation, atrial flutter, ventricular premature beats, and paroxysmal supraventricular tachycardia. Possesses extensive surgical experience in interventional treatments and radiofrequency ablation for various arrhythmias, performing over 600 radiofrequency ablation surgeries annually. Awarded as an Outstanding Graduate of Shanghai, received the Second Prize of the 2019 Chinese Medical Science and Technology Award, and was selected for the 2020 Shanghai Young Talents Sailing Program. Published more than ten papers as the first author and co-first author, including seven SCI-indexed articles, and contributed to the second and third editions of the monograph "Catheter Ablation for Atrial Fibrillation." Actively participates in public education on atrial fibrillation and other common cardiovascular diseases, with short video views exceeding tens of millions on platforms like Douyin and Video Accounts, amassing over 200,000 followers. Awarded the 2023 Shanghai Atrial Fibrillation Center Alliance “Advanced Individual Award for Atrial Fibrillation Public Education.”

 END 



【ShineyoMedical RhythPulse®-PFA System】

ShineyoMedical's RhythPulse®-PFA System is the first approved Pulse Field Ablation (PFA) system in China that integrates multi-channel, large focal, and targeted ablation, primarily used for treating drug-refractory and recurrent atrial fibrillation and other types of rapid arrhythmias. Its core advantages include:

Large Focal Spot Design:Using the world's first 10mm ring ablation catheter, a single discharge can cover a lesion area with a diameter of 10mm, increasing the ablation efficiency by more than three times compared to traditional technology.

Targeted Ablation Technology:Equipped with an intelligent contact detection module, it monitors the contact status between the electrode and myocardial tissue in real time, reducing the risk of hemolysis caused by ineffective discharges, and decreasing postoperative plasma free hemoglobin content by 50%.

Excellent Clinical Validation:In a clinical trial involving 151 cases, the immediate success rate was 100%, and the success rate for atrial fibrillation treatment at 12 months post-operation reached 85.07%, meeting internationally leading standards.


Image